Genta Initiates Pilot Clinical Trial Of Genasense(R) Plus Abraxane(R) And Temodar(R) As First-Line Therapy For Patients (Medical News Today)
Genta Initiates Pilot Clinical Trial Of Genasense(R) Plus Abraxane(R) And Temodar(R) As First-Line Therapy For Patients (Medical News Today)
Genta Incorporated (Nasdaq: GNTA) announced that the Company has initiated a new clinical study that will evaluate the Company’s lead anticancer drug, Genasense(R) (oblimersen sodium) Injection in patients with advanced melanoma. [click link for full article]